PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

bok%3A978-1-4939-0515-7.pdf ?auth66=1397940469_51b8ba57efa3ddcad3f8aa303951bc25&ext=

Frontiers Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis

Safety monitoring of drug-induced muscle injury and rhabdomyolysis: a biomarker-guided approach for clinical practice and drug trials

PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

triglyc-drugs-Image001.jpg

2018 Guidelines for the Management of Dyslipidemia in Korea

Coenzyme Q10 and Statin Myalgia: What is the Evidence?

PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers

Vitamins

Improving Cardiovascular Risk Assessment to Optimize Therapy

PDF) Narrative Review: Statin-Related Myopathy